Get the Stockscreener App
12.65
0.80%
0.095
Elanco Animal Health Inc stock is traded at $12.65, with a volume of 1.27M.
It is up +0.80% in the last 24 hours and down -13.64% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$12.56
Open:
$12.45
24h Volume:
1.27M
Relative Volume:
0.29
Market Cap:
$6.26B
Revenue:
$4.49B
Net Income/Loss:
$-1.26B
P/E Ratio:
-63.27
EPS:
-0.2
Net Cash Flow:
$425.00M
1W Performance:
+1.20%
1M Performance:
-13.64%
6M Performance:
-6.43%
1Y Performance:
+31.74%
1-Day Range:
$12.35
$12.77
1-Week Range:
$12.35
$12.83
52-Week Range:
$9.26
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
2500 INNOVATION WAY, GREENFIELD
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
Pet Medication Market: Comprehensive Analysis and Key Players-Zoetis, Merck, Merial, Elanco, Bayer. - openPR
ELAN LAWSUIT ALERT: BFA Law Announces Elanco Animal Health has been Sued for Securities Fraud and Urges Investors to Contact the Firm by December 6 Deadline - Newsfile
Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - PR Newswire
The Gross Law Firm Notifies Elanco Animal Health Incorporated In - GuruFocus.com
Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile– Hagens Berman - GlobeNewswire
Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile– Hagens Berman - GlobeNewswire Inc.
Elanco Animal Health (ELAN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
ELAN LAWSUIT ALERT: A Securities Fraud Class Action has - GlobeNewswire
2024-11-04 | ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing
Class Action Filed Against Elanco Animal Health Incorporated (ELAN) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire
Animal Parasiticides Market Anticipated for Positive Growth - openPR
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elanco Animal - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Elanco Animal Health Incorporated Investors to - The Bakersfield Californian
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - PR Newswire
Elanco Animal Health Incorporated (NYSE:ELAN) Position Increased by Harbor Capital Advisors Inc. - MarketBeat
2024-11-03 | ELAN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing
ELAN Investors Have Opportunity to Lead Elanco Animal Health Inc - GuruFocus.com
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus.com
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming DeadlinesELAN - PR Newswire
Private Management Group Inc. Increases Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
ELAN (Elanco Animal Health) Cyclically Adjusted FCF per Sha - GuruFocus.com
ELAN (Elanco Animal Health) Other Current Assets : $904 Mil (As of Jun. 2024) - GuruFocus.com
ELANCO ANIMAL HEALTH has been Sued for Securities Fraud - GlobeNewswire
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit - PR Newswire
Elanco Animal Health Incorporated Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationELAN - PR Newswire
Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile – Hagens Berman - GlobeNewswire
ELAN CLASS ACTION: Elanco Animal Health Investors with - GlobeNewswire
Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
The Gross Law Firm Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - PR Newswire
Raymond James & Associates Sells 777,405 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Levi & Korsinsky Reminds Elanco Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 6, 2024ELAN - PR Newswire
ELAN DEADLINE NOTICE: Elanco Animal Health Investors are - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
White River State Park announces a 15-acre waterfront expansion - INDYtoday
Action Alert: Elanco Securities Class Action Deadline Approaches - CEO Today
White River State Park reveals plans for $65M expansion on stamping plant site - Daily Journal
ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Elanco Animal Health (NYSE:ELAN) Price Target Cut to $19.00 - MarketBeat
Europe Companion Animal Health Market Report Analysis - openPR
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 6, 2024 in Elanco LawsuitELAN - PR Newswire
ELAN FRAUD ALERT: BFA Law Notifies Elanco Animal Health - GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elanco - GlobeNewswire
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
1.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):